Home Newsfeeds Mizuho Maintains Buy on Haemonetics, Raises Price Target to $100

Mizuho Maintains Buy on Haemonetics, Raises Price Target to $100

Mizuho analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $90 to $100.

byBenzinga Newsdesk

November 8, 2022

1 minute read

Mizuho analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $90 to $100.

Analyst Ratings

Expert Ratings for Cracker Barrel Old

By Benzinga Insights

December 20, 4:05 PM

Within the last quarter, Cracker Barrel Old (NASDAQ:CBRL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…

CBRL

Does Defeat Mean Death For Putin? ‘If You Fail, You Will Be Killed,’ Says Palantir CEO Alex Karp

By Adam Eckert

September 22, 12:23 PM

In a rare address to the nation in September, Russian President Vladamir Putin made it clear he wouldn't hold back from using nuclear weapons in defense of Russia.

PLTR

Apple’s Longest-Serving Designer Bart Andre To Retire, Marking End Of Jony Ive Era

By Ananya Gairola

February 13, 9:33 PM

Bart Andre, Apple Inc.'s longest-serving senior industrial designer and a key figure in the company's product aesthetic, has decided to retire, signaling a significant turnover in the design team that once operated under Jony Ive's leadership.

AAPL

RBC Capital Markets Initiates Coverage On This ‘Well Positioned’ Pet Company

By Vandana Singh

September 7, 3:34 PM

RBC Capital Markets initiated Petco Health and Wellness Company Inc (NASDAQ: WOOF) with an Outperform rating and a $17 price target.

WOOF

Mizuho Maintains Buy on Haemonetics, Raises Price Target to $100

Related Posts

Expert Ratings for Cracker Barrel Old

Does Defeat Mean Death For Putin? ‘If You Fail, You Will Be Killed,’ Says Palantir CEO Alex Karp

Apple’s Longest-Serving Designer Bart Andre To Retire, Marking End Of Jony Ive Era

RBC Capital Markets Initiates Coverage On This ‘Well Positioned’ Pet Company